, Danik M., Mennicken F., Williams S., Quirion R. (2006). Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation, BMC Neurosci, 7, 28.

Kopala L., Smith G., Malla A., Williams S., Love L., Talling D., Balshaw R. (2006). Resource utilization in a Canadian national study of people with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 29-39.

Malla A., Williams S., Kopala L., Smith G., Talling D., Balshaw R. (2006). Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders, Acta Psychiatr Scand Suppl(430), 22-8.

Smith G., Malla A., Williams S., Kopala L., Love L., Balshaw R. (2006). The Canadian National Outcomes Measurement Study in Schizophrenia: overview of the patient sample and methodology, Acta Psychiatr Scand Suppl(430), 4-11.

Williams S., Kopala L., Malla A., Smith G., Love L., Balshaw R. (2006). Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia, Acta Psychiatr Scand Suppl(430), 12-21.